Back to Search Start Over

Centre Leon Berard Researchers Update Current Data on Cancer (Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort).

Source :
Clinical Trials Week; 7/31/2023, p163-163, 1p
Publication Year :
2023

Abstract

According to the news editors, the research concluded: "Sorafenib showed activity in progressive patients with solid tumors harboring somatic genomic alterations in sorafenib-targeted genes. Keywords: Cancer; Health and Medicine; Oncology EN Cancer Health and Medicine Oncology 163 163 1 07/31/23 20230731 NES 230731 2023 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- A new study on cancer is now available. [Extracted from the article]

Subjects

Subjects :
SORAFENIB
CANCER patients

Details

Language :
English
ISSN :
15436772
Database :
Complementary Index
Journal :
Clinical Trials Week
Publication Type :
Periodical
Accession number :
167379997